SCHEMBL2807187

SCHEMBL2807187

CCCSC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1016347 0.79
SCHEMBL5586119 0.77
SCHEMBL27990354 0.77 TSHR (0.46)
SCHEMBL27819007 0.77 TSHR (0.46)
Hydroxyl Radical SCHEMBL6567953 0.76
SCHEMBL2244165 0.72
SCHEMBL8022546 0.72 TDP1 (0.30)
SCHEMBL8022550 0.72 TDP1 (0.30)
SCHEMBL8190611 0.72
SCHEMBL25443890 0.72 SLC22A1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100237770-A1 GOLD COMPLEX AND PROCESS FOR PREPARING THE SAME, AND ORGANIC ULTRAVIOLET ELECTROLUMINESCENT DEVICE USING SAID GOLD COMPLEX UBE INDUSTRIES, LTD. (JP) 2010-09-23 US claimed
EP-2088151-A1 GOLD COMPLEX, METHOD FOR PRODUCTION OF THE GOLD COMPLEX, AND ORGANIC ULTRAVIOLET ELECTROLUMINESCENT ELEMENT USING THE GOLD COMPLEX Ube Industries, Ltd. (JP) 2009-08-12 EP claimed
US-12258349-B2 Anti-viral drug DORING INTERNATIONAL GMBH (CH) 2025-03-25 US disclosed
US-20220298164-A1 ANTI-VIRAL DRUG DORING INTERNATIONAL GMBH (CN) 2022-09-22 US disclosed
US-11370797-B2 Anti-viral drug DORING INTERNATIONAL GMBH (CH) 2022-06-28 US disclosed
EP-3194411-B1 NUCLEOTIDE ANALOGS UNIV CALIFORNIA (US) 2022-05-04 EP disclosed
EP-3943500-A1 PHOSPHOROUS PROTECTING GROUPS AND METHODS OF PREPARATION AND USE THEREOF Agilent Technologies, Inc. (US) 2022-01-26 EP disclosed
EP-3875462-A1 NUCLEOTIDE ANALOGS The Regents of The University of California (US) 2021-09-08 EP disclosed
WO-2016153949-A1 5-DEUTERO-THIAZOLIDINE-2,4-DIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME DEUTERX, LLC (US) 2016-09-29 WO disclosed
WO-2010151160-A1 O-SUBSTITUTED 3-N-HETEROARYL-1,3,4-OXADIAZOLONES FOR MEDICAL USE BIAL - PORTELA & CA., S.A. (PT) 2010-12-29 WO disclosed
EP-2238131-A1 5-O-SUBSTITUTED 3-N-PHENYL-1,3,4-OXADIAZOLONES FOR MEDICAL USE BIAL - Portela & Ca., S.A. (PT) 2010-10-13 EP disclosed
EP-1319666-A1 Novel antibacterial compounds Sankyo Company, Limited (JP) 2003-06-18 EP disclosed
US-20030092754-A1 External preparation for skin diseases containing nitroimidazole SHOEI CO., LTD. (JP) 2003-05-15 US disclosed
US-20030069204-A1 Strain of streptomyces SANKYO COMPANY LIMITED (JP) 2003-04-10 US disclosed
US-6472384-B1 Antimicrobial compounds SANKYO COMPANY, LIMITED (JP) 2002-10-29 US disclosed
EP-1206937-A1 NITROIMIDAZOLE EXTERNAL PREPARATIONS FOR DERMATOSIS SHOEI CO., LTD. (JP) 2002-05-22 EP disclosed
EP-1095947-A1 NOVEL ANTIBACTERIAL COMPOUNDS Sankyo Company Limited (JP) 2001-05-02 EP disclosed
EP-0001753-B1 THIOPHOSPHORIC(PHOSPHONIC) ACID ESTERS, PROCESS FOR THEIR PREPARATION AND USE AS PESTICIDES BASF Aktiengesellschaft (DE) 1980-12-10 EP disclosed
US-4203977-A PESTICIDES BASF AKTIENGESELLSCHAFT (DE) 1980-05-20 US disclosed
EP-0001753-A1 Thiophosphoric(phosphonic) acid esters, process for their preparation and use as pesticides BASF Aktiengesellschaft (DE) 1979-05-16 EP disclosed